Loading company
Vyome Holdings, Inc
HIND · Nasdaq · ·
$2.01-1.5%Sep 29 close
- 1M
- -8.8%
- 6M
- -1.5%
- 1Y
- -61.2%
- 5Y
- -100.0%
HIND · Nasdaq · ·
$2.01-1.5%Sep 29 close
The quarter ending June 30, 2026, against the same quarter a year earlier.
| Measure | 3 months toJun 30, 2026 | 3 months toJun 30, 2025 | Change |
|---|---|---|---|
| Total Revenue | $27K | $1.2M | -97.83% |
| Profit | -$685.6K | -$308.8K | -122.04% |
| Profit per share | -$0.10 | -$0.26 | +60.91% |
| Free Cash Flow | -$2.5M | -$2.9M | +15.51% |
These are single quarters, not a trailing year — the figures elsewhere on this site cover twelve months and will be much larger. A seasonal business swings a long way between the two: ServiceNow earns $2.0B of free cash flow in its December quarter and $0.5B in its June one.
Compared against the same quarter a year earlier, not against an analyst forecast. A “beat” or “miss” needs a consensus estimate, which is licensed data we do not carry — and getting it wrong is worse than leaving it out.
Vyome Holdings, Inc has no earnings call transcript available.
Releases land after the close or before the open, so the move is the session that follows.
Holdings, Inc.: Vyome is building the world’s premier platform spanning the US-India innovation corridor. Vyome’s immediate focus is on leveraging its clinical-stage assets to transform the lives of patients with immuno-inflammatory conditions. By applying groundbreaking science and its unique positioning, Vyome seeks to deliver lasting value to shareholders in a hyper cost-efficient manner while upholding global standards of quality and safety. To learn more, please visit www.vyometx.com
The company’s own description, as it appears at the foot of the release.
The quote and the company description come from Vyome Holdings, Inc’s Item 2.02 8-K filed August 25, 2026; the table is built from its quarterly reports. Read the release on EDGAR Share prices are split- and dividend-adjusted.